Article

Carl Zeiss Meditec AG achieves 10,000th placement of diagnostic device

Carl Zeiss Meditec AG placed its 10,000th diagnostic system (IOLMaster) at a customer site earlier this month. The system calculates all necessary eye measurements for determining the most appropriate replacement implant lens during cataract surgery.

Carl Zeiss Meditec AG placed its 10,000th diagnostic system (IOLMaster) at a customer site earlier this month. The system calculates all necessary eye measurements for determining the most appropriate replacement implant lens during cataract surgery.

Also a completely noninvasive biometry system, the device does not make contact with the patient's eye. The diagnostic system quickly and conveniently measures axial length as well as corneal curvature and anterior chamber depth, according to the company. The alternative for ophthalmologists is ultrasound, a diagnostic procedure that is more time consuming, less accurate, and less comfortable for the patient, the company said.

"We chose to invest in the [diagnostic system] because it is the most accurate method for determining the best lens for our cataract patients," said Douglas Liva, MD, who is in private practice in Paramus, NJ. "The system is more precise, easier to operate, and, ultimately, more comfortable for our patients than immersion ultrasound. For doctors [who] are implanting premium lenses, this technology is essential to the practice in terms of clinical benefits, technician workflow, and patient satisfaction."

In two separate studies conducted by Wolfgang Haigis, PhD, and Warren Hill, MD, more than 95% of all patients with cataracts were measurable. Using state-of-the-art calculation methods, even IOLs for cataract patients who have previously undergone refractive laser correction can be determined easily, according to the company.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.